Skip to main content
Top
Published in: Endocrine 1/2013

01-02-2013 | Original Article

No conclusive evidence for association of polymorphisms in the adiponectin receptor 1 gene, AdipoR1, with common obesity

Authors: S. Beckers, F. de Freitas, D. Zegers, I. L. Mertens, A. Verrijken, J. K. Van Camp, L. F. Van Gaal, W. Van Hul

Published in: Endocrine | Issue 1/2013

Login to get access

Abstract

AdipoR1 is one of the adiponectin receptors which are important for adiponectin signaling. Because adiponectin is a candidate gene for common obesity, it is also hypothesized that variations in AdipoR1 may be involved in the development of complex obesity. Therefore, we designed an association study for the AdipoR1 gene. We performed a case–control association study including 1,021 obese subjects (mean age 42 ± 12 years; mean BMI 38.2 ± 6.2 kg/m²) and 226 lean, healthy individuals (mean age 36 ± 7 years; mean BMI 22.1 ± 1.7 kg/m²). Nine tagSNPs were selected to cover the entire AdipoR1 gene and surrounding 7 kb region (based on HapMap data). TagSNPs were genotyped using AcycloPrime-Fluorescence Polarization (FP) SNP Detection kits and TaqMan Pre-Designed SNP Genotyping assays according to manufacturer’s protocols. We found that the rs1075399 non-reference allele decreases obesity risk by 45 % in men only [odds ratio (OR) = 0.55, 95 % CI 0.35–0.87, nominal P = 0.010]. However, after Bonferroni correction for multiple testing, this association is lost. None of the other tagSNPs were associated with obesity when studying the entire population, nor when looking at men and women separately. Quantitative analysis of the effect of each SNP on height, weight, and BMI revealed that none of the tagSNPs are associated with weight or BMI. We report here that we found no decisive evidence for association between AdipoR1 tagSNPs and complex obesity in our Belgian Caucasian population.
Literature
2.
go back to reference P.G. Kopelman, Obesity as a medical problem. Nature 404(6778), 635–643 (2000)PubMed P.G. Kopelman, Obesity as a medical problem. Nature 404(6778), 635–643 (2000)PubMed
3.
go back to reference L.F. Van Gaal, I.L. Mertens, C.E. De Block, Mechanisms linking obesity with cardiovascular disease. Nature 444(7121), 875–880 (2006)PubMedCrossRef L.F. Van Gaal, I.L. Mertens, C.E. De Block, Mechanisms linking obesity with cardiovascular disease. Nature 444(7121), 875–880 (2006)PubMedCrossRef
4.
go back to reference N. Bouatia-Naji, D. Meyre, S. Lobbens, K. Seron, F. Fumeron, B. Balkau, B. Heude, B. Jouret, P.E. Scherer, C. Dina, J. Weill, P. Froguel, ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 55(2), 545–550 (2006)PubMedCrossRef N. Bouatia-Naji, D. Meyre, S. Lobbens, K. Seron, F. Fumeron, B. Balkau, B. Heude, B. Jouret, P.E. Scherer, C. Dina, J. Weill, P. Froguel, ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 55(2), 545–550 (2006)PubMedCrossRef
5.
go back to reference R.J. Loos, S. Ruchat, T. Rankinen, A. Tremblay, L. Perusse, C. Bouchard, Adiponectin and adiponectin receptor gene variants in relation to resting metabolic rate, respiratory quotient, and adiposity-related phenotypes in the Quebec family study. Am. J. Clin. Nutr. 85(1), 26–34 (2007)PubMed R.J. Loos, S. Ruchat, T. Rankinen, A. Tremblay, L. Perusse, C. Bouchard, Adiponectin and adiponectin receptor gene variants in relation to resting metabolic rate, respiratory quotient, and adiposity-related phenotypes in the Quebec family study. Am. J. Clin. Nutr. 85(1), 26–34 (2007)PubMed
6.
go back to reference S. Beckers, A.V. Peeters, F. de Freitas, I.L. Mertens, S.L. Verhulst, D. Haentjens, K.N. Desager, L.F. Van Gaal, W. Van Hul, Association study and mutation analysis of adiponectin shows association of variants in APM1 with complex obesity in women. Ann. Hum. Genet. 73(Pt 5), 492–501 (2009)PubMedCrossRef S. Beckers, A.V. Peeters, F. de Freitas, I.L. Mertens, S.L. Verhulst, D. Haentjens, K.N. Desager, L.F. Van Gaal, W. Van Hul, Association study and mutation analysis of adiponectin shows association of variants in APM1 with complex obesity in women. Ann. Hum. Genet. 73(Pt 5), 492–501 (2009)PubMedCrossRef
7.
go back to reference W. Du, Q. Li, Y. Lu, X. Yu, X. Ye, Y. Gao, J. Ma, J. Cheng, Y. Cao, J. Du, H. Shi, L. Zhou, Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case–control study of Chinese Han population. Endocrine 40(3), 413–422 (2011)PubMedCrossRef W. Du, Q. Li, Y. Lu, X. Yu, X. Ye, Y. Gao, J. Ma, J. Cheng, Y. Cao, J. Du, H. Shi, L. Zhou, Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case–control study of Chinese Han population. Endocrine 40(3), 413–422 (2011)PubMedCrossRef
8.
go back to reference H. Jia, L. Yu, X. Guo, W. Gao, Z. Jiang, Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis. Endocrine (2012). doi:10.1007/s12020-012-9605-3 H. Jia, L. Yu, X. Guo, W. Gao, Z. Jiang, Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis. Endocrine (2012). doi:10.​1007/​s12020-012-9605-3
9.
go back to reference T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, T. Kadowaki, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423(6941), 762–769 (2003)PubMedCrossRef T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, T. Kadowaki, Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423(6941), 762–769 (2003)PubMedCrossRef
10.
go back to reference A. Coope, M. Milanski, E.P. Araujo, M. Tambascia, M.J. Saad, B. Geloneze, L.A. Velloso, AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus. FEBS Lett. 582(10), 1471–1476 (2008)PubMedCrossRef A. Coope, M. Milanski, E.P. Araujo, M. Tambascia, M.J. Saad, B. Geloneze, L.A. Velloso, AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus. FEBS Lett. 582(10), 1471–1476 (2008)PubMedCrossRef
11.
go back to reference M. Bjursell, A. Ahnmark, Y.M. Bohlooly, L. William-Olsson, M. Rhedin, X.R. Peng, K. Ploj, A.K. Gerdin, G. Arnerup, A. Elmgren, A.L. Berg, J. Oscarsson, D. Linden, Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56(3), 583–593 (2007)PubMedCrossRef M. Bjursell, A. Ahnmark, Y.M. Bohlooly, L. William-Olsson, M. Rhedin, X.R. Peng, K. Ploj, A.K. Gerdin, G. Arnerup, A. Elmgren, A.L. Berg, J. Oscarsson, D. Linden, Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56(3), 583–593 (2007)PubMedCrossRef
12.
go back to reference S.A. Miller, D.D. Dykes, H.F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16(3), 1215 (1988)PubMedCrossRef S.A. Miller, D.D. Dykes, H.F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16(3), 1215 (1988)PubMedCrossRef
13.
go back to reference P.I. de Bakker, R. Yelensky, I. Pe’er, S.B. Gabriel, M.J. Daly, D. Altshuler, Efficiency and power in genetic association studies. Nat. Genet. 37(11), 1217–1223 (2005)PubMedCrossRef P.I. de Bakker, R. Yelensky, I. Pe’er, S.B. Gabriel, M.J. Daly, D. Altshuler, Efficiency and power in genetic association studies. Nat. Genet. 37(11), 1217–1223 (2005)PubMedCrossRef
15.
go back to reference W.J. Gauderman, J.M. Morrison, QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra.usc.edu/gxe (2006). Accessed 19 Apr 2011 W.J. Gauderman, J.M. Morrison, QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. http://​hydra.​usc.​edu/​gxe (2006). Accessed 19 Apr 2011
16.
go back to reference C.M. Damcott, S.H. Ott, T.I. Pollin, L.J. Reinhart, J. Wang, J.R. O’Connel, B.D. Mitchell, A.R. Shuldiner, Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes 54(7), 2245–2250 (2005)PubMedCrossRef C.M. Damcott, S.H. Ott, T.I. Pollin, L.J. Reinhart, J. Wang, J.R. O’Connel, B.D. Mitchell, A.R. Shuldiner, Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes 54(7), 2245–2250 (2005)PubMedCrossRef
17.
go back to reference N. Stefan, F. Machicao, H. Staiger, J. Machann, F. Schick, O. Tschritter, C. Spieth, C. Weigert, A. Fritsche, M. Stumvoll, H.U. Haring, Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48(11), 2282–2291 (2005)PubMedCrossRef N. Stefan, F. Machicao, H. Staiger, J. Machann, F. Schick, O. Tschritter, C. Spieth, C. Weigert, A. Fritsche, M. Stumvoll, H.U. Haring, Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48(11), 2282–2291 (2005)PubMedCrossRef
18.
go back to reference S.C. Collins, J. Luan, A.J. Thompson, A. Daly, R.K. Semple, S. O’Rahilly, N.J. Wareham, I. Barroso, Adiponectin receptor genes: mutation screening in syndromes of insulin resistance and association studies for type 2 diabetes and metabolic traits in UK populations. Diabetologia 50(3), 555–562 (2007)PubMedCrossRef S.C. Collins, J. Luan, A.J. Thompson, A. Daly, R.K. Semple, S. O’Rahilly, N.J. Wareham, I. Barroso, Adiponectin receptor genes: mutation screening in syndromes of insulin resistance and association studies for type 2 diabetes and metabolic traits in UK populations. Diabetologia 50(3), 555–562 (2007)PubMedCrossRef
19.
go back to reference L. Qi, A. Doria, E. Giorgi, F.B. Hu, Variations in adiponectin receptor genes and susceptibility to type 2 diabetes in women: a tagging-single nucleotide polymorphism haplotype analysis. Diabetes 56(6), 1586–1591 (2007)PubMedCrossRef L. Qi, A. Doria, E. Giorgi, F.B. Hu, Variations in adiponectin receptor genes and susceptibility to type 2 diabetes in women: a tagging-single nucleotide polymorphism haplotype analysis. Diabetes 56(6), 1586–1591 (2007)PubMedCrossRef
20.
go back to reference E. Yeh, L. Kimura, F.I. Errera, C.B. Angeli, R.C. Mingroni-Netto, M.E. Silva, L.H. Canani, M.R. Passos-Bueno, Association of polymorphisms at the ADIPOR1 regulatory region with type 2 diabetes and body mass index in a Brazilian population with European or African ancestry. Braz. J. Med. Biol. Res. (Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica et al.) 41(6), 468–472 (2008) E. Yeh, L. Kimura, F.I. Errera, C.B. Angeli, R.C. Mingroni-Netto, M.E. Silva, L.H. Canani, M.R. Passos-Bueno, Association of polymorphisms at the ADIPOR1 regulatory region with type 2 diabetes and body mass index in a Brazilian population with European or African ancestry. Braz. J. Med. Biol. Res. (Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica et al.) 41(6), 468–472 (2008)
21.
go back to reference T.L. Edwards, D.R. Velez Edwards, R. Villegas, S.S. Cohen, M.S. Buchowski, J.H. Fowke, D. Schlundt, J.R. Long, Q. Cai, W. Zheng, X.O. Shu, M.K. Hargreaves, S. Jeffrey, S.M. Williams, L.B. Signorello, W.J. Blot, C.E. Matthews, HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a cohort of Caucasians and African Americans: an evaluation of gene–environment interactions and candidate genes. Am. J. Epidemiol. 175(1), 11–21 (2012)PubMedCrossRef T.L. Edwards, D.R. Velez Edwards, R. Villegas, S.S. Cohen, M.S. Buchowski, J.H. Fowke, D. Schlundt, J.R. Long, Q. Cai, W. Zheng, X.O. Shu, M.K. Hargreaves, S. Jeffrey, S.M. Williams, L.B. Signorello, W.J. Blot, C.E. Matthews, HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a cohort of Caucasians and African Americans: an evaluation of gene–environment interactions and candidate genes. Am. J. Epidemiol. 175(1), 11–21 (2012)PubMedCrossRef
22.
go back to reference S.S. Cohen, M.D. Gammon, K.E. North, R.C. Millikan, E.M. Lange, S.M. Williams, W. Zheng, Q. Cai, J. Long, J.R. Smith, L.B. Signorello, W.J. Blot, C.E. Matthews, ADIPOQ, ADIPOR1, and ADIPOR2 polymorphisms in relation to serum adiponectin levels and BMI in black and white women. Obesity 19(10), 2053–2062 (2011)PubMedCrossRef S.S. Cohen, M.D. Gammon, K.E. North, R.C. Millikan, E.M. Lange, S.M. Williams, W. Zheng, Q. Cai, J. Long, J.R. Smith, L.B. Signorello, W.J. Blot, C.E. Matthews, ADIPOQ, ADIPOR1, and ADIPOR2 polymorphisms in relation to serum adiponectin levels and BMI in black and white women. Obesity 19(10), 2053–2062 (2011)PubMedCrossRef
23.
go back to reference N. Siitonen, L. Pulkkinen, U. Mager, J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, J. Tuomilehto, M. Laakso, M. Uusitupa, Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. Diabetologia 49(8), 1795–1805 (2006)PubMedCrossRef N. Siitonen, L. Pulkkinen, U. Mager, J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, J. Tuomilehto, M. Laakso, M. Uusitupa, Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. Diabetologia 49(8), 1795–1805 (2006)PubMedCrossRef
24.
go back to reference D.K. Richardson, J. Schneider, M.J. Fourcaudot, L.M. Rodriguez, R. Arya, T.D. Dyer, L. Almasy, J. Blangero, M.P. Stern, R.A. Defronzo, R. Duggirala, C.P. Jenkinson, Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. Diabetologia 49(10), 2317–2328 (2006)PubMedCrossRef D.K. Richardson, J. Schneider, M.J. Fourcaudot, L.M. Rodriguez, R. Arya, T.D. Dyer, L. Almasy, J. Blangero, M.P. Stern, R.A. Defronzo, R. Duggirala, C.P. Jenkinson, Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. Diabetologia 49(10), 2317–2328 (2006)PubMedCrossRef
25.
go back to reference The 1000 Genomes Project Consortium, A map of human genome variation from population-scale sequencing. Nature 467(7319), 1061–1073 (2010) The 1000 Genomes Project Consortium, A map of human genome variation from population-scale sequencing. Nature 467(7319), 1061–1073 (2010)
Metadata
Title
No conclusive evidence for association of polymorphisms in the adiponectin receptor 1 gene, AdipoR1, with common obesity
Authors
S. Beckers
F. de Freitas
D. Zegers
I. L. Mertens
A. Verrijken
J. K. Van Camp
L. F. Van Gaal
W. Van Hul
Publication date
01-02-2013
Publisher
Springer US
Published in
Endocrine / Issue 1/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9736-6

Other articles of this Issue 1/2013

Endocrine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine